LISA RECCHIONE: Open Payments
NPI 1184864720 · PAOLI, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 4 payments from 4 companies in 2025. Trend: 2023 $150 · 2024 $250 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $127 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $114 |
Products named: LYBALVI, UZEDY, INGREZZA, REXULTI.
Industry payments across PA — which companies pay providers there.
